Home » Topics » BioWorld Science

BioWorld Science
RSS

Funding supports LUNAC-led project to develop next-generation anticoagulant

Dec. 3, 2019

BiomX completes enrollment in cosmetic clinical study of BX-001 in acne-prone skin

Dec. 3, 2019

Akari announces trial design for pivotal phase III study of nomacopan in pediatric HSCT-TMA

Dec. 3, 2019

Celyad opens enrollment in phase I trial of CYAD-1 for relapsed/refractory AML or MDS

Dec. 3, 2019

New cholesterol target works independently of LDL receptor

Dec. 3, 2019

Meta-analysis reveals universally altered genes in early AD

Dec. 3, 2019

Phase IIb trial of Amphora for prevention of chlamydia and gonorrhea meets primary endpoint

Dec. 2, 2019

Concert initiates phase II study of CTP-692 as adjunctive treatment in schizophrenia

Dec. 2, 2019

Proof-of-concept study of SENS-111 in acute unilateral vestibulopathy misses primary endpoint

Dec. 2, 2019

Aslan reports preliminary proof-of-concept data on ASLAN-004 in atopic dermatitis

Dec. 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...